147 related articles for article (PubMed ID: 20580163)
1. Second-line chemotherapy for small-cell lung cancer (SCLC).
Kim YH; Mishima M
Cancer Treat Rev; 2011 Apr; 37(2):143-50. PubMed ID: 20580163
[TBL] [Abstract][Full Text] [Related]
2. Topotecan in the treatment of recurrent small cell lung cancer: an update.
Ardizzoni A
Oncologist; 2004; 9 Suppl 6():4-13. PubMed ID: 15616145
[TBL] [Abstract][Full Text] [Related]
3. Effective combination chemotherapy of carboplatin and paclitaxel in the treatment of a recurrent small-cell lung cancer patient.
Kaira K; Ishizuka T; Yanagitani N; Sunaga N; Hisada T; Mori M
Gan To Kagaku Ryoho; 2007 Feb; 34(2):225-7. PubMed ID: 17301532
[TBL] [Abstract][Full Text] [Related]
4. A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer.
Shibayama T; Hotta K; Takigawa N; Tada A; Ueoka H; Harita S; Kiura K; Tabata M; Segawa Y; Nogami N; Kuyama S; Shinkai T; Tanimoto M
Lung Cancer; 2006 Aug; 53(2):189-95. PubMed ID: 16806573
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
6. Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402.
Inoue A; Sugawara S; Yamazaki K; Maemondo M; Suzuki T; Gomi K; Takanashi S; Inoue C; Inage M; Yokouchi H; Watanabe H; Tsukamoto T; Saijo Y; Ishimoto O; Hommura F; Nukiwa T
J Clin Oncol; 2008 Nov; 26(33):5401-6. PubMed ID: 18854562
[TBL] [Abstract][Full Text] [Related]
7. European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.
Ardizzoni A; Manegold C; Debruyne C; Gaafar R; Buchholz E; Smit EF; Lianes P; ten Velde G; Bosquee L; Legrand C; Neumaier C; King K;
Clin Cancer Res; 2003 Jan; 9(1):143-50. PubMed ID: 12538462
[TBL] [Abstract][Full Text] [Related]
8. Emerging drugs for small-cell lung cancer.
Metro G; Cappuzzo F
Expert Opin Emerg Drugs; 2009 Dec; 14(4):591-606. PubMed ID: 19694501
[TBL] [Abstract][Full Text] [Related]
9. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
[TBL] [Abstract][Full Text] [Related]
10. Topotecan in small cell lung cancer.
Schiller JH
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-27-S20-33. PubMed ID: 9425958
[TBL] [Abstract][Full Text] [Related]
11. The role of ifosfamide in small cell lung cancer.
Loehrer PJ
Semin Oncol; 1996 Jun; 23(3 Suppl 7):40-4. PubMed ID: 8711501
[TBL] [Abstract][Full Text] [Related]
12. [Recent topics in chemotherapy for elderly patients with lung cancer].
Okamoto H; Watanabe K
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1097-104. PubMed ID: 10945002
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in management of small-cell lung cancer.
Chua YJ; Steer C; Yip D
Cancer Treat Rev; 2004 Oct; 30(6):521-43. PubMed ID: 15325033
[TBL] [Abstract][Full Text] [Related]
14. New advances in the second-line treatment of small cell lung cancer.
Hurwitz JL; McCoy F; Scullin P; Fennell DA
Oncologist; 2009 Oct; 14(10):986-94. PubMed ID: 19819917
[TBL] [Abstract][Full Text] [Related]
15. [Recent progress in chemotherapy for advanced lung cancer].
Negoro S; Fukuoka M
Gan To Kagaku Ryoho; 1995 Mar; 22(4):451-60. PubMed ID: 7887637
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of weekly topotecan in recurrent small cell lung cancer.
Eckardt JR
Oncologist; 2004; 9 Suppl 6():25-32. PubMed ID: 15616147
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer.
Lorigan P; Lee SM; Betticher D; Woodhead M; Weir D; Hanley S; Hardy C; Thatcher N
Semin Oncol; 1995 Jun; 22(3 Suppl 7):32-41. PubMed ID: 7610397
[TBL] [Abstract][Full Text] [Related]
18. Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials.
Bozcuk H; Artac M; Ozdogan M; Savas B
Cancer; 2005 Dec; 104(12):2650-7. PubMed ID: 16284984
[TBL] [Abstract][Full Text] [Related]
19. [Evidence based chemotherapy for lung cancer].
Watanabe H; Saijo N
Gan To Kagaku Ryoho; 2000 Jan; 27(1):30-43. PubMed ID: 10660731
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]